Azilect and Restoril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azilect (rasagiline mesylate) and Restoril (temazepam). Common drug interactions include death among females and depression among males.

The phase IV clinical study analyzes what interactions people have when they take Azilect and Restoril. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Azilect?

Azilect has active ingredients of rasagiline mesylate. It is often used in parkinson's disease. eHealthMe is studying from 8,622 Azilect users. Check the latest studies of Azilect.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.



On Jul, 15, 2026

12 people who take Azilect and Restoril together, and have interactions are studied.

Azilect and Restoril drug interactions.

What are the common drug interactions of Azilect and Restoril, by gender? *:

female:

  1. Death
  2. Fatigue (feeling of tiredness)
  3. Gait disturbance

male:

  1. Depression
  2. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  3. Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
  4. Bile duct stenosis (abnormal narrowing of the common bile duct)
  5. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  6. Dementia (madness)
  7. Infection
  8. Mobility decreased (ability to move is reduced)
  9. Peripheral coldness
  10. Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired)

What are the common drug interactions of Azilect and Restoril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Aspartate aminotransferase increased
  2. Blood alkaline phosphatase increased
  3. Blood bilirubin increased
  4. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  5. Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
  6. Bile duct stenosis (abnormal narrowing of the common bile duct)

30-39:

n/a

40-49:

n/a

50-59:

  1. Fatigue (feeling of tiredness)
  2. Gait disturbance

60+:

  1. Death
  2. Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired)

What are the existing conditions these people have? *

  1. Depression: 5 people, 41.67%
  2. Stress And Anxiety: 4 people, 33.33%
  3. Pain: 4 people, 33.33%
  4. Nausea (feeling of having an urge to vomit): 4 people, 33.33%
  5. Drowsiness: 4 people, 33.33%
  6. Back Pain: 4 people, 33.33%
  7. Abdominal Pain: 4 people, 33.33%
  8. Malignant Melanoma (skin cancer rises from melancytes): 2 people, 16.67%
  9. Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 8.33%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Azilect and Restoril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azilect and Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azilect:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azilect and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restoril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on rasagiline mesylate and temazepam (the active ingredients of Azilect and Restoril, respectively), and Azilect and Restoril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: